179 related articles for article (PubMed ID: 37662039)
1. A network meta-analysis of therapeutic and prophylactic management of vasospasm on aneurysmal subarachnoid hemorrhage outcomes.
Chousterman B; Leclère B; Morisson L; Eude Y; Gayat E; Mebazaa A; Cinotti R
Front Neurol; 2023; 14():1217719. PubMed ID: 37662039
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.
Dayyani M; Sadeghirad B; Grotta JC; Zabihyan S; Ahmadvand S; Wang Y; Guyatt GH; Amin-Hanjani S
Stroke; 2022 Jun; 53(6):1993-2005. PubMed ID: 35354302
[TBL] [Abstract][Full Text] [Related]
3. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
[TBL] [Abstract][Full Text] [Related]
5. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
[TBL] [Abstract][Full Text] [Related]
6. Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.
Thompson JC; Chalet FX; Manalastas EJ; Hawkins N; Sarri G; Talbot DA
Neurol Ther; 2022 Jun; 11(2):597-620. PubMed ID: 35441974
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
[TBL] [Abstract][Full Text] [Related]
8. Clinical Burden of Angiographic Vasospasm and Its Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review.
Chalet FX; Briasoulis O; Manalastas EJ; Talbot DA; Thompson JC; Macdonald RL
Neurol Ther; 2023 Apr; 12(2):371-390. PubMed ID: 36609962
[TBL] [Abstract][Full Text] [Related]
9. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
Wang X; Li YM; Li WQ; Huang CG; Lu YC; Hou LJ
PLoS One; 2012; 7(10):e47778. PubMed ID: 23082215
[TBL] [Abstract][Full Text] [Related]
10. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
[TBL] [Abstract][Full Text] [Related]
11. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Song J; Xue YQ; Wang YJ; Xu P; Sun DK; Chen W
World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness and safety of clazosentan in treating aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
Al-Salihi MM; Saha R; Abd Elazim A; Helal A; Sabah Al-Jebur M; Al-Salihi Y; Ayyad A
J Clin Neurosci; 2024 Jun; 126():173-181. PubMed ID: 38924824
[TBL] [Abstract][Full Text] [Related]
13. Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis.
Grossen AA; Ernst GL; Bauer AM
Neurosurg Focus; 2022 Mar; 52(3):E10. PubMed ID: 35231885
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol for Aneurysmal Subarachnoid Hemorrhage: An Updated Systematic Review and Meta-Analysis.
Liu J; He J; Chen X; Feng Y; Wang C; Awil MA; Wang Y; Tian Y; Hou D
Cerebrovasc Dis; 2022; 51(2):138-148. PubMed ID: 35288494
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
[TBL] [Abstract][Full Text] [Related]
16. Effects of Various Therapeutic Agents on Vasospasm and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage-Results of a Network Meta-Analysis.
Mishra S; Garg K; Gaonkar VB; Singh PM; Singh M; Suri A; Chandra PS; Kale SS
World Neurosurg; 2021 Nov; 155():41-53. PubMed ID: 34339892
[TBL] [Abstract][Full Text] [Related]
17. Role of Cilostazol in Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage-A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
Bohara S; Garg K; Singh Rajpal PM; Kasliwal M
World Neurosurg; 2021 Jun; 150():161-170. PubMed ID: 33631387
[TBL] [Abstract][Full Text] [Related]
18. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
Vergouwen MD; de Haan RJ; Vermeulen M; Roos YB
Stroke; 2010 Jan; 41(1):e47-52. PubMed ID: 19875741
[TBL] [Abstract][Full Text] [Related]
19. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
Romero Kräuchi O; Verger Bennasar AM
Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
[TBL] [Abstract][Full Text] [Related]
20. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]